Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial.
- DOI
- 10.1016/j.eclinm.2025.103594
- Published
- 2025 Dec
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2025.103594,
title = {Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial.},
author = {Lobo R and Angulo A and Muñoz A and Colli E and Escobar-Morreale HF and Luque-Ramírez M and Zatik J and Regidor PA},
year = {2025},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2025.103594},
url = {https://doi.org/10.1016/j.eclinm.2025.103594}
}RIS
TY - JOUR TI - Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial. AU - Lobo R AU - Angulo A AU - Muñoz A AU - Colli E AU - Escobar-Morreale HF AU - Luque-Ramírez M AU - Zatik J AU - Regidor PA PY - 2025 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2025.103594 UR - https://doi.org/10.1016/j.eclinm.2025.103594 ER -
APA
R, L., A, A., A, M., E, C., HF, E., M, L., J, Z., & PA, R. (2025). Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2025.103594
Source records
- pubmed · retrieved 2026-09-26T19:14:07.360Z